Review article: defining remission in ulcerative colitis
about
Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitisTreating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Review article: acute severe ulcerative colitis - evidence-based consensus statements.Circulating ghrelin levels and obestatin/ghrelin ratio as a marker of activity in ulcerative colitis.Role of wireless capsule endoscopy in the follow-up of inflammatory bowel disease.Magnifying Endoscopic Findings Can Predict Clinical Outcome during Long-Term Follow-Up of More Than 12 Months in Patients with Ulcerative ColitisLycopene, Lutein and Zeaxanthin May Reduce Faecal Blood, Mucus and Pus but not Abdominal Pain in Individuals with Ulcerative Colitis.Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialOnce-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.Ulcerative colitis or Crohn's disease? Pitfalls and problems.Current and emerging maintenance therapies for ulcerative colitis.Endoscopic scoring systems for inflammatory bowel disease: pros and cons.Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.Conventional drug therapy for inflammatory bowel disease.Vedolizumab: A New Opponent in the Battle Against Crohn's Disease and Ulcerative Colitis.Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease.Assessing disease activity in patients with ulcerative colitis.Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.Review article: the histological assessment of disease activity in ulcerative colitis.Psychometric validation of the SF-36(®) Health Survey in ulcerative colitis: results from a systematic literature review.Symptom clusters in adults with inflammatory bowel disease.Acute severe ulcerative colitis: from pathophysiology to clinical management.Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population.Evaluating clinical, dietary and psychological risk factors for relapse of ulcerative colitis in clinical, endoscopic and histological remission.Conventional treatment regimens for ulcerative colitis alleviate fatigue - an observational cohort study.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative ColitisThe prognostic value of histology in ulcerative colitis in clinical remission with mesalazinePillCam colon capsule endoscopy versus conventional colonoscopy for the detection of severity and extent of ulcerative colitis.Assessment of histological remission in ulcerative colitis: discrepancies between daily practice and expert opinion.Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study.Fatigue in out-patients with inflammatory bowel disease is common and multifactorial.Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis.Acute severe ulcerative colitis: latest evidence and therapeutic implications.Development and validation of the Nancy histological index for UC.
P2860
Q24202978-B2176CA5-AC21-4FAC-AD12-90982E72C2F4Q34008773-918FFC0D-D12F-4BD7-B693-2C1864ABAAB1Q34047972-89FA170C-F7F6-4A8D-9803-FEC53116597DQ34528270-17F141B7-B949-4D39-80A0-CCBB8DF77D95Q35046209-A81E4C24-8DFF-4383-8679-726D50FB3664Q35709756-F06880F4-26A7-4095-BFCE-4587412EA3B0Q37253332-58DC5836-D148-4B51-A22D-084C7127646DQ37373864-2076F5E1-8C00-42E5-9489-9F76E7497078Q37387994-6166E804-F0C0-4329-8B9D-AC5373C711BBQ37561775-5D67EF49-A533-4353-9F3A-F65E7FF7DD84Q37600339-D48AA2F0-3D55-4919-AF0A-CE48662DF794Q38132555-2BCC5DBA-D2CB-4246-8163-595EF28CEE9CQ38165241-DE6F3A10-6B24-4F7C-8194-7BE58CB7C300Q38197719-0E80A95B-3B0A-4745-94E5-1F2B1F861774Q38197726-CAC7FD9D-BE8F-4B83-8834-1E68988AF662Q38293774-7296E90D-24BD-48AA-9957-6A0651E36790Q38293796-B9FC4DA8-C392-46D3-9169-04C047B8B652Q38465723-2B23C97F-A1D5-40C3-AC43-EF3B551A6341Q38475858-FABB5DE8-5A12-40A2-824B-FA0A824D5827Q38519730-BA2E6F04-F3BF-4441-BD17-9DDB62EB9F12Q38531008-983141B6-2812-4B83-9262-E3369811095BQ38573248-375D1F75-F5BE-458B-88F8-8F983442E4DDQ38604435-DA0EF80F-2284-4B14-87EF-00C1EFF3345EQ38612265-F9F62756-17EA-43FB-9113-CA0B2AE96BB2Q38942561-3DCD3C5F-3ECB-4691-AF6F-CD7CA5E3ECDBQ39179611-35398DA1-3D0C-4D08-95B3-493682802555Q39414345-6F1F07BB-0865-4828-88DA-595AA1F02A76Q40324273-31296ECC-43A5-4B9C-991E-16AA5AA6F322Q40697506-C8EE50CA-5AB7-4F15-81A4-7FA0BB64143EQ40926333-0EE04BC0-196B-4ADA-B152-434FDFD306BEQ41980696-02EE265B-B61B-4991-BD9D-35174E16333DQ42375644-44716B29-3F09-4C79-B54D-7A746E7D25EAQ43550951-28222887-CE72-4A68-A086-6DDE1A848EE9Q47310047-03598966-FC50-4ADA-839B-B61A88B7692BQ47942430-728FA9AE-F2EE-41E2-BAF5-085DF1024F0FQ48437869-A32F15EF-D3E9-43F5-BF2E-391FFE383EA8Q48552671-F937DCE1-4AE5-484F-B714-1174F60FA512Q49213214-680E0077-FD90-412F-A5E2-F2CC691F62FFQ49232336-27F5E9ED-D8C3-4633-9B58-A6AD83465869Q50793198-9110CE96-6A3B-4670-88AF-B00D919CB438
P2860
Review article: defining remission in ulcerative colitis
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Review article: defining remission in ulcerative colitis
@ast
Review article: defining remission in ulcerative colitis
@en
Review article: defining remission in ulcerative colitis
@nl
type
label
Review article: defining remission in ulcerative colitis
@ast
Review article: defining remission in ulcerative colitis
@en
Review article: defining remission in ulcerative colitis
@nl
prefLabel
Review article: defining remission in ulcerative colitis
@ast
Review article: defining remission in ulcerative colitis
@en
Review article: defining remission in ulcerative colitis
@nl
P2093
P3181
P1476
Review article: defining remission in ulcerative colitis
@en
P2093
C J Van Der Woude
C O'Morain
P D R Higgins
R Panaccione
S P L Travis
P304
P3181
P356
10.1111/J.1365-2036.2011.04701.X
P407
P577
2011-07-01T00:00:00Z